ReviR Therapeutics today announced a strategic investment from CureCMT to support the launch of a precision medicine platform for Charcot-Marie-Tooth disease (CMT). The platform will combine isogenic ...

Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease. SAN FRANCISCO and SHANGHAI, March 2, 2026 /PRNewswire/ -- ReviR Therapeutics, a ...

The two companies will work to develop treatments for SBMA. ReviR Therapeutics is partnering with Kennedy’s Disease Association to advance treatments for spinal and bulbar muscular atrophy (SBMA). 1 ...

"We know the tsunami of digital evidence is a challenge for our clients and true to our culture, we are focused on solving their pain points. Revir helps Tyler deliver for our clients and their ...

RTX-117 is an investigational small molecule designed to modulate the Integrated Stress Response (ISR) pathway, with the goal of restoring protein translation homeostasis implicated in ...

These funds will be used to further augment ReviR's AI-driven drug discovery VoyageR platform, which will be leveraged to advance proprietary chemical matter for novel and undruggable targets and to ...

Since new Mac-specific malware is pretty rare, I suppose I can't really ignore the malware that most AV companies are calling Revir.A (the dropper and downloader) and Imuler.A (the backdoor that ...

The company plans to develop these treatments using it’s AI-powered platform. ReviR Therapeutics announced that it has secured $30 million in Series A financing, which will be used to augment the ...

BRISBANE, Calif., Nov. 26, 2024 /PRNewswire/ -- ReviR Therapeutics, a pioneering biotechnology company focused on developing novel small molecule RNA modulators for neurogenetic diseases, announced a ...

Not unexpectedly, a variant of the Revir Trojan for OS X that was found a week or two ago has been found. Topher, an avid Mac user for the past 15 years, has been a contributing author to MacFixIt ...

BRISBANE, Calif., July 26, 2024 /PRNewswire/ -- ReviR Therapeutics, an AI-enabled biotechnology company focused on developing small molecule RNA modulators for neurogenetic diseases, announced today ...